Pharmaceutics International, Inc. - Form 483, 2014-02-26

Document Details

Document Type:
FDA 483
Inspection Duration:
February, 2014 - February, 2014
Site:
Pharmaceutics International, Inc. [Hunt Valley / United States of America]
FEI:
1000513101
Investigator(s):
Toyin B Oladimeji, Nebil A Oumer
Redica ID:
100108834

Ready to purchase?

$289 - Available for instant download

Buy Now
FDA 483 - Pharmaceutics International, Inc. [Hunt Valley / United States of America] - Download PDF - Redica Systems

Experience Redica Systems’ NEW AI document analysis for 483 documents and observations

Redica Systems customers can leverage the full Quality and Regulatory Intelligence suite, with powerful analysis covering over 900,000 inspection records, over 62,000 documents, and over 141,000 searchable observations.

The interactive 483 element below is not an example of the specific 483 highlighted at the top of this page.

Data layers
Example FDA 483 document
Example FDA 483 document - Objects highlighted
Example FDA 483 document - Object Attributes highlighted
Example FDA 483 document - Labels highlighted

If you just need this specific document, you can quickly add it to your cart and check out. On the other hand, if you’d like to experience the full analytical functionality of Redica Systems, fill out the form below to get in touch with our Sales Team.

Ready to get your hands on our new AI analyzed documents?

Loading...

FDA 483’s Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to our extensive inventory of FDA 483 documents, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more